Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Jul 12, 2018 at 8:50 AM EDT

Where Did Major Pharma Short Sellers Go?

The June 29 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 12, 2018 at 8:21 AM EDT

Short Sellers Back Off Major Biotechs

The June 29 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Jul 11, 2018 at 1:20 PM EDT

Akcea Therapeutics Jumps on European Marketing Approval

Akcea Therapeutics shares saw a nice bump on Wednesday after the company announced in conjunction with Ionis Pharmaceuticals that they…

Chris Lange | Jul 11, 2018 at 11:05 AM EDT

BioCryst Shareholders Back Out of Idera Merger

Idera Pharmaceuticals shares crumbled on Wednesday after BioCryst Pharmaceuticals announced that it terminated the merger agreement.

Chris Lange | Jul 11, 2018 at 10:15 AM EDT

AbbVie Slumps on Late-Stage Lymphoma Trial

AbbVie shares dipped on Wednesday after the company gave a less than impressive update from its late-stage lymphoma trial.

Chris Lange | Jul 10, 2018 at 11:20 AM EDT

Replimune Closes in on IPO

Biotechnology company Replimune intends to price more than 6 million shares in an initial public offering valued up to more…

Chris Lange | Jul 10, 2018 at 9:45 AM EDT

Celgene and Acceleron Pharma Win Again in Late-Stage Trial

Acceleron Pharma and Celgene each saw a handy gain on Tuesday morning after it was announced results from their late-stage…

Chris Lange | Jul 9, 2018 at 12:05 PM EDT

Axovant Wins With Key Licensing Agreement

Axovant Sciences shares saw a handy gain on Monday after the company announced that it has licensed exclusive global rights…

Chris Lange | Jul 9, 2018 at 10:40 AM EDT

Constellation Pharma Closes in on IPO

Constellation Pharmaceuticals intends to price more than 5 million shares to result in an initial public offering valued up to…

Chris Lange | Jul 9, 2018 at 10:30 AM EDT

KemPharm Dips Despite Positive ADHD Trial Results

KemPharm shares dipped on Monday after the firm announced topline results from its ADHD clinical trial.

Chris Lange | Jul 7, 2018 at 8:15 AM EDT

Major Biopharma Catalysts on July’s FDA Calendar

Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates…

Chris Lange | Jul 6, 2018 at 8:35 AM EDT

Biogen Wins Big With Midstage Alzheimer’s Study

Biogen shares jumped early on Friday after the firm, in conjunction with Eisai, announced positive results from a midstage Alzheimer’s…

Chris Lange | Jul 5, 2018 at 9:45 AM EDT

Why Zynerba Shares Are Getting Crushed

Zynerba Pharmaceuticals shares were crushed early on Thursday after the company reported topline results from an early stage clinical study.

Chris Lange | Jul 5, 2018 at 8:55 AM EDT

Clovis Breaks Into Europe With EMA Validation

Clovis Oncology shares saw a bump early on Thursday after the company announced that the European Medicines Agency has validated…

Chris Lange | Jul 3, 2018 at 10:05 AM EDT

Why Juniper Pharmaceuticals Shares Jumped

Juniper Pharmaceuticals shares jumped early on Tuesday after the company announced that it would be acquired by Catalent.

1 … 126 127 128 129 130 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Where Did Major Pharma Short Sellers Go?

Short Sellers Back Off Major Biotechs

Akcea Therapeutics Jumps on European Marketing Approval

BioCryst Shareholders Back Out of Idera Merger

AbbVie Slumps on Late-Stage Lymphoma Trial

Replimune Closes in on IPO

Celgene and Acceleron Pharma Win Again in Late-Stage Trial

Axovant Wins With Key Licensing Agreement

Constellation Pharma Closes in on IPO

KemPharm Dips Despite Positive ADHD Trial Results

Major Biopharma Catalysts on July’s FDA Calendar

Biogen Wins Big With Midstage Alzheimer’s Study

Why Zynerba Shares Are Getting Crushed

Clovis Breaks Into Europe With EMA Validation

Why Juniper Pharmaceuticals Shares Jumped

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Health and Healthcare Articles

All Health and Healthcare Articles

Where Did Major Pharma Short Sellers Go?

Short Sellers Back Off Major Biotechs

Akcea Therapeutics Jumps on European Marketing Approval

BioCryst Shareholders Back Out of Idera Merger

AbbVie Slumps on Late-Stage Lymphoma Trial

Replimune Closes in on IPO

Celgene and Acceleron Pharma Win Again in Late-Stage Trial

Axovant Wins With Key Licensing Agreement

Constellation Pharma Closes in on IPO

KemPharm Dips Despite Positive ADHD Trial Results

Major Biopharma Catalysts on July’s FDA Calendar

Biogen Wins Big With Midstage Alzheimer’s Study

Why Zynerba Shares Are Getting Crushed

Clovis Breaks Into Europe With EMA Validation

Why Juniper Pharmaceuticals Shares Jumped

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

Featured Reads

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how